Low-Dose of Bergamot-Derived Polyphenolic Fraction (BPF) Did Not Improve Metabolic Parameters in Second Generation Antipsychotics-Treated Patients: Results from a 60-days Open-Label Study

Objectives: The nutraceutical approach to the management of metabolic syndrome (MetS) might be a promising strategy in the prevention of cardio-metabolic risk. Low-dose bergamot-derived polyphenolic fraction (BPF) has been proven effective in patients with MetS, as demonstrated by a concomitant impr...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruno, Antonio, Pandolfo, Gianluca, Crucitti, Manuela, Cacciola, Massimo, Santoro, Vincenza, Spina, Edoardo, Zoccali, Rocco A., Muscatello, Maria R. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387046/
https://www.ncbi.nlm.nih.gov/pubmed/28443024
http://dx.doi.org/10.3389/fphar.2017.00197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387046/
https://www.ncbi.nlm.nih.gov/pubmed/28443024
http://dx.doi.org/10.3389/fphar.2017.00197

Ejemplares similares